comparemela.com

Bio Marker Pathfinder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript

Bio-Techne Corporation beats earnings expectations. Reported EPS is $0.48, expectations were $0.46.

South koreaUnited statesJim hippelWilliam blairKim keldermanCatherine schulteMatt larewPuneet soudaWilson wolfPatrick donnellyJacob johnsonBio techne rnascope hiplexDavid clairJustin bowersDan ariasOur protein sciences

BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY

MINNEAPOLIS, April 26, 2024 /PRNewswire/ Bio-Techne Corporation and Novomol-Dx, a molecular diagnostics company, are pleased to announce the development of Bio-Marker Pathfinder , a first of.

Naren shettyNarayana nethralayaArkasubhra ghoshBio techne ellaDavid clairRohit shettyBio techne protein sciences segmentBio techne corporationNarayana nethralaya foundationInvestor relations corporate developmentBio marker pathfinderGrow laboratoriesDry eye diseaseDiabetic retinopathyWill geistProtein sciences

vimarsana © 2020. All Rights Reserved.